Delivery Order SPE2DB24D2101-SPE2DB25FKJER

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.40 firm fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The firm-fixed-price delivery order has a ceiling value of $1,176.22 and an ultimate completion date of March 11, 2025. The contract is not designated under a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,003.04, is a delivery order for the pharmaceutical product Lantus SoloStar (insulin glargine) 100 unit/mL 3mL. The contract has a firm fixed price and an ultimate completion date of March 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,697.74 and is a delivery order for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract is a firm fixed-price agreement with an ultimate completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,431.92, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin. It is a Firm Fixed Price Delivery Order contract with a completion date of December 27, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,187.60, is a Firm Fixed Price Delivery Order for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The award has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,104.77 firm-fixed-price delivery order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,848.13 Firm Fixed Price delivery order contract is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialized insulin medication used to treat diabetes. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. This delivery order is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,821.14 firm fixed price delivery order is for 4566054659 LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication product. The contract has an ultimate completion date of October 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,425.12 firm fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The award has an ultimate completion date of February 27, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKJER
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,196.25, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin product. It is a firm fixed price delivery order contract with an ultimate completion date of April 4, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award referenced is a specific delivery order under this larger IDC. No set-aside designation was used for this contract.

Generated 7/3/25, 2:46 PM